Prostate Cancer Screening With Abbreviated MRI Protocol (ProstaPilot)
Prostate Cancer
About this trial
This is an interventional prevention trial for Prostate Cancer focused on measuring magnetic resonance imaging, biparametric MRI, prostate cancer, PI-RADS, PSA, preventive medicine
Eligibility Criteria
Inclusion Criteria: Age 50-69 years Life expectancy over 10 years Ability to undergo all planned procedures (without contraindications to MRI or biopsy) No known prostate cancer or prostate biopsy in the past (interventions for BPH are not a restriction) No PSA test or prostate MRI in the past 2 years. No signs of prostatitis or urinary tract infection in the past 6 months. Signed informed consent. Exclusion Criteria: Contraindications to MRI Hip replacement Known BRCA1/BRCA2 mutation
Sites / Locations
- Masaryk Memorial Cancer InstituteRecruiting
Arms of the Study
Arm 1
Experimental
Preventive prostate examination by bpMRI
The cohort consists of patients: with age 50-69 years without any contraindications to MRI or biopsy without known status of prostate cancer or prostate biopsy in the past (interventions for BPH are not a restriction) without known BRCA mutation without PSA test or prostate MRI in the past 2 years without any signs of prostatitis or urinary tract infection in the past 6 months.